Search

everythinglearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

ALRN-6924 may prevent hair loss caused by chemotherapy.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Serenoa repens extract, alone or with other supplements, improves urinary symptoms and lowers PSA levels.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

MOTILIPERM may help treat male infertility by reducing stress in cells.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

A new method was developed to make finasteride for treating hair loss.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Udenafil may help hair grow by activating certain stem cells.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Dutasteride microinfusion and microneedling both effectively treat male hair loss.

The combination of encorafenib and binimetinib caused few skin issues.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

The dutasteride nanoemulsion could improve hair loss treatment by enhancing drug penetration and retention in hair follicles.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

The formulation with oleic acid may be better for treating male pattern baldness.